leisure time -WSS

leisure time

author：comprehensive 2025-09-27 12:21:47 - browse：76716

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Medicare drug price lawsuits could be good politics for Biden

WSS

Innovation in antibiotics is ailing. 'Brain drain' may kill it

To bolster infectious disease surveillance, genomics powerhouses team up

See how much Covid

Medicare drug price lawsuits could be good politics for Biden

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Let's speed up science by embracing open access publishing

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

Hollywood unions extend contract negotiations for actors

Let's speed up science by embracing open access publishing

Bright Health sells Medicare Advantage business to Molina

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Guidelines to prevent youth baseball injuries need more muscle

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Jerome Adams on the need for new antivirals for Covid

Future doctors need a strong humanities education

Supreme Court strikes down use of affirmative action

Prior authorization reform is both possible and imperative

leisure time

Cord blood banking comes at a high cost to babies

Head of FDA's diagnostics center, who led through Covid, retires

Cardiologists urge adding sexual orientation, gender identity to health records

See how much Covid

Woman returns to dialysis after doctors remove transplanted pig kidney

What causes osteoarthritis? Researchers study link to brain protein

focus

entertainment

entertainment

hotspot